Sector performance

SectorsIndustriesCompanies
1-year trend
Today's change
Health Care52,765
1.38%
Top industriesToday's
change		Top companiesLastToday's
change
Biotechnology+2.00%Jagson Pal Pharmaceuticals LtdJAGSNPHARM:NSI16.55
INR		+2.75
+19.93%
Pharmaceuticals+1.67%PledPharma publ ABPLED:STO17.60
SEK		+2.60
+17.33%
Health Care Providers+1.04%MediBic Group2369:TYO395.00
JPY		+54.00
+15.84%
Medical Supplies+0.29%Genovis ABGENO:STO4.40
SEK		+0.58
+15.18%
Medical Equipment+0.16%Egalet CorpEGLT:NMQ12.30
USD		+1.58
+14.74%
Consumer Services164,804
1.08%
Financials2020,583
0.52%
Technology74,289
0.48%
Basic Materials106,104
0.32%
Telecommunications2449
0.45%
Consumer Goods196,348
0.18%
Industrials209,933
0.49%
Utilities5966
0.18%
Oil & Gas62,286
0.03%

Sector news

Apr 23 2014 09:17 BST
Primark looks to US with Boston store
Primark is taking the cheap chic that has won fans in Europe to the US, as it becomes latest British store group to forge into America
Apr 23 2014 09:10 BST
Patisserie Valerie chain owner seeks IPO
Initial public offering backed by Luke Johnson is latest in series by retail companies seeking to tap investors as consumer confidence rises
Apr 23 2014 09:03 BST
Arm Holdings’ royalties growth slows
Reported revenues rose 16% year on year in dollar terms, but there was slower growth in royalties as demand for more expensive mobile devices cools
Apr 23 2014 08:54 BST
Woolworths chief preaches power of size
When Woolworths unveiled plans to splash out A$2.14bn on Australia’s David Jones, it touted deal as one that would create southern hemisphere champion
Quindell shares regain some lost groundAllergan hits back in pharma deals frenzy
Silicon Valley investor urges governance fixNumericable eyes record €8.5bn junk sale
Citi 2013 pay awards backed by investorsGM recall sparks battle over liability
Companies news
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.